Mechanistic description
The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.
Mechanism / pathway
- RNA
- neurodegeneration
Evidence for (1)
The proposed priority experiment is concrete: time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography
Evidence against (1)
Therapeutic tractability is not established by the current source evidence.
Evidence matrix
Supporting
- The proposed priority experiment is concrete: time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography 10.1021/acs.chemrev.4c00138
Contradicting
- Therapeutic tractability is not established by the current source evidence. 10.1021/acs.chemrev.4c00138
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Perturbation-first validation should precede therapeutic claims for Biophysical…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c34258ddeb
@misc{scidex_hypothesis_hc34258d,
title = {Perturbation-first validation should precede therapeutic claims for Biophysical…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-c34258ddeb},
note = {SciDEX artifact hypothesis:h-c34258ddeb}
}